Over the past 12 months, 5 insiders at 10x Genomics, Inc. filed 25 open-market SEC Form 4 transactions on TXG: 0 purchases worth $0 and 25 sales worth $5.2M. Insiders have been net sellers over this period. The most recent filing was on Jun 22, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 22, 26 | Serge SaxonovChief Executive Officer | SELL | 10.0K | $36.16 | $347K |
| Jun 16, 26 | Shehnaaz Suliman | SELL | 5.4K | $33.27 | $175K |
| May 26, 26 | Serge SaxonovChief Executive Officer | SELL | 10.7K | $24.71 | $265K |
| May 22, 26 | Benjamin J. HindsonSee Remarks | SELL | 11.6K | $24.44 | $283K |
| May 22, 26 | Serge SaxonovChief Executive Officer | SELL | 18.2K | $24.44 | $444K |
| May 22, 26 | Adam TaichChief Financial Officer | SELL | 15.1K | $24.44 | $369K |
| Apr 14, 26 | Serge SaxonovChief Executive Officer | SELL | 5.0K | $24.56 | $123K |
| Mar 24, 26 | Serge SaxonovChief Executive Officer | SELL | 5.0K | $19.52 | $98K |
| Mar 23, 26 | Serge SaxonovChief Executive Officer | SELL | 10.0K | $19.13 | $191K |
| Mar 2, 26 | Serge SaxonovChief Executive Officer | SELL | 14.3K | $23.18 | $324K |
| Feb 25, 26 | Sarah A. TeichmannDirector | SELL | 7.6K | $19.41 | $147K |
| Feb 23, 26 | Benjamin J. HindsonSee Remarks | SELL | 7.8K | $18.58 | $145K |
| Feb 23, 26 | Serge SaxonovChief Executive Officer | SELL | 9.6K | $18.58 | $179K |
| Feb 23, 26 | Adam TaichChief Financial Officer | SELL | 9.0K | $18.58 | $167K |
| Nov 24, 25 | Benjamin J. HindsonSee Remarks | SELL | 8.3K | $19.00 | $157K |
| Nov 24, 25 | Serge SaxonovChief Executive Officer | SELL | 13.3K | $19.00 | $252K |
| Nov 24, 25 | Adam TaichChief Financial Officer | SELL | 11.9K | $19.00 | $226K |
| Aug 22, 25 | Benjamin J. HindsonSee Remarks | SELL | 7.5K | $13.79 | $103K |
| Aug 22, 25 | Serge SaxonovChief Executive Officer | SELL | 9.3K | $13.79 | $129K |
| Aug 22, 25 | Adam TaichChief Financial Officer | SELL | 22.3K | $13.79 | $308K |
| May 22, 25 | Benjamin J. HindsonSee Remarks | SELL | 7.5K | $8.30 | $62K |
| May 22, 25 | Serge SaxonovChief Executive Officer | SELL | 9.3K | $8.30 | $78K |
| May 22, 25 | Adam TaichChief Financial Officer | SELL | 4.0K | $8.30 | $34K |
| Feb 28, 25 | Serge SaxonovChief Executive Officer | SELL | 7.9K | $10.63 | $84K |
| Feb 24, 25 | Benjamin J. HindsonSee Remarks | SELL | 4.6K | $11.07 | $51K |
| Feb 24, 25 | Serge SaxonovChief Executive Officer | SELL | 5.1K | $11.07 | $56K |
| Feb 21, 25 | Alan MateoDirector | BUY | 40.0K | $11.14 | $446K |
| Nov 22, 24 | Benjamin J. HindsonSee Remarks | SELL | 5.8K | $13.69 | $79K |
| Nov 22, 24 | Serge SaxonovChief Executive Officer | SELL | 6.7K | $13.69 | $92K |
| Aug 22, 24 | Benjamin J. HindsonSee Remarks | SELL | 4.4K | $22.53 | $98K |
| Aug 22, 24 | Justin J. McAnearOther | SELL | 3.0K | $22.53 | $67K |
| Aug 22, 24 | Serge SaxonovChief Executive Officer | SELL | 6.7K | $22.53 | $152K |
| May 22, 24 | Benjamin J. HindsonSee Remarks | SELL | 4.1K | $24.30 | $99K |
| May 22, 24 | Justin J. McAnearChief Financial Officer | SELL | 2.9K | $24.30 | $71K |
| May 22, 24 | Serge SaxonovChief Executive Officer | SELL | 4.9K | $24.30 | $119K |
| Mar 4, 24 | Serge SaxonovChief Executive Officer | SELL | 4.7K | $44.00 | $205K |
| Feb 22, 24 | Benjamin J. HindsonSee Remarks | SELL | 2.6K | $46.34 | $121K |
| Feb 22, 24 | Justin J. McAnearChief Financial Officer | SELL | 1.9K | $46.34 | $86K |
| Feb 22, 24 | Serge SaxonovChief Executive Officer | SELL | 2.8K | $46.34 | $131K |
| Feb 15, 24 | Serge SaxonovChief Executive Officer | SELL | 3.3K | $49.43 | $160K |
| Feb 9, 24 | Serge SaxonovChief Executive Officer | SELL | 1.0K | $49.53 | $50K |
| Jan 16, 24 | Serge SaxonovChief Executive Officer | SELL | 3.0K | $45.65 | $134K |
| Dec 14, 23 | Serge SaxonovChief Executive Officer | SELL | 1.7K | $55.15 | $94K |
| Nov 24, 23 | Serge SaxonovChief Executive Officer | SELL | 3.7K | $43.72 | $163K |
| Nov 22, 23 | Benjamin J. HindsonSee Remarks | SELL | 3.4K | $43.34 | $149K |
| Nov 22, 23 | Justin J. McAnearChief Financial Officer | SELL | 1.7K | $43.34 | $73K |
| Nov 22, 23 | Serge SaxonovChief Executive Officer | SELL | 3.8K | $43.34 | $163K |
| Nov 22, 23 | James WilburChief Commercial Officer | SELL | 3.5K | $43.34 | $150K |
| Nov 20, 23 | James WilburChief Commercial Officer | SELL | 14.7K | $42.09 | $619K |
| Nov 14, 23 | Serge SaxonovChief Executive Officer | SELL | 2.0K | $39.52 | $79K |
Over the past 12 months, insiders at 10x Genomics, Inc. filed 0 open-market purchases worth $0 and 25 sales worth $5.2M on TXG, which makes them net sellers over the period. The most recent Form 4 was filed on Jun 22, 26.
The largest recent open-market TXG insider purchase in our data was $446K by Alan Mateo, Director, filed on Feb 21, 25.
5 different insiders at 10x Genomics, Inc. filed open-market SEC Form 4 transactions on TXG over the last 12 months.
InsiderTape plots every TXG insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every 10x Genomics, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →